Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Svanevik

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Gastroenterology|November 6, 2022
Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional studyKathrine Aglen Seeberg, Dag Hofsø, Heidi Borgeraas, et al.
The Lancet. Diabetes & Endocrinology|July 6, 2023
Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trialMarius Svanevik, Jolanta Lorentzen, Heidi Borgeraas, et al.
JAMA Surgery|September 15, 2016
Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical TrialHilde Risstad, Marius Svanevik, Jon A Kristinsson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2021
Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg)Farhat Fatima, Jøran Hjelmesæth, Kåre Inge Birkeland, et al.
Obesity Surgery|March 21, 2020
Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional StudyJolanta Lorentzen, Asle W Medhus, Jens Kristoffer Hertel, et al.
BJS Open|November 18, 2021
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trialOdd Bjørn Kjeldaas Salte, Marius Svanevik, Hilde Risstad, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
Health Science Reports|January 25, 2021
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscriptsEinar Kristian Borud, Espen Rostrup Nakstad, Siri Eldevik Håberg, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2025
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trialJostein Wågen Hauge, Heidi Borgeraas, Kåre Inge Birkeland, et al.
Ebiomedicine|March 21, 2025
Chromatin landscape in paired human visceral and subcutaneous adipose tissue and its impact on clinical variables in obesitySadia Saeed, Lars la Cour Poulsen, Tina Visnovska, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Gastroenterology|November 6, 2022
Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional studyKathrine Aglen Seeberg, Dag Hofsø, Heidi Borgeraas, et al.
The Lancet. Diabetes & Endocrinology|July 6, 2023
Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trialMarius Svanevik, Jolanta Lorentzen, Heidi Borgeraas, et al.
JAMA Surgery|September 15, 2016
Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical TrialHilde Risstad, Marius Svanevik, Jon A Kristinsson, et al.
The Journal of Clinical Endocrinology and Metabolism|August 31, 2021
Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg)Farhat Fatima, Jøran Hjelmesæth, Kåre Inge Birkeland, et al.
Obesity Surgery|March 21, 2020
Erosive Esophagitis and Symptoms of Gastroesophageal Reflux Disease in Patients with Morbid Obesity with and without Type 2 Diabetes: a Cross-sectional StudyJolanta Lorentzen, Asle W Medhus, Jens Kristoffer Hertel, et al.
BJS Open|November 18, 2021
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trialOdd Bjørn Kjeldaas Salte, Marius Svanevik, Hilde Risstad, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
Health Science Reports|January 25, 2021
Severe acute respiratory syndrome coronavirus 2 prevalence in 1170 asymptomatic Norwegian conscriptsEinar Kristian Borud, Espen Rostrup Nakstad, Siri Eldevik Håberg, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2025
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trialJostein Wågen Hauge, Heidi Borgeraas, Kåre Inge Birkeland, et al.
Ebiomedicine|March 21, 2025
Chromatin landscape in paired human visceral and subcutaneous adipose tissue and its impact on clinical variables in obesitySadia Saeed, Lars la Cour Poulsen, Tina Visnovska, et al.
Pageof 3